Status:
COMPLETED
A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients
Lead Sponsor:
NeuraLight
Conditions:
Idiopathic Parkinson Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a prospective study in a cohort of about 500 patients with Idiopathic Parkinson's disease, examined routinely in the neurological outpatient clinic. This study aims to evaluate the correlatio...
Detailed Description
This is a prospective study in a cohort of patients with idiopathic PD who are visiting the Parkinson's outpatient clinic. The aim of the study is to evaluate the correlation between oculometric measu...
Eligibility Criteria
Inclusion
- PD patients:
- Men and women with idiopathic PD (Hoehn \& Yahr scale 1-5)
- Age between 18 and 85 years old
- Normal or corrected vision
- Ability to follow instructions
- Willing and able to sign an informed consent form
Exclusion
- Inability to sit for 20 minutes on a chair in a calm manner
- Personal or 1st degree relative history of epilepsy
- Additional neurological diseases
- Drug or alcohol abuse
- Healthy subjects:
- Inclusion Criteria:
- Age between 18 and 85 years old
- Normal or corrected vision
- Ability to follow instructions
- Willing and able to sign an informed consent form
- Exclusion Criteria
- Inability to sit for 20 minutes on a chair in a calm manner
- Personal or 1st degree relative history of epilepsy
- Neurological diseases
- Drug or alcohol abuse
Key Trial Info
Start Date :
August 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2024
Estimated Enrollment :
465 Patients enrolled
Trial Details
Trial ID
NCT05437003
Start Date
August 20 2022
End Date
February 15 2024
Last Update
February 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel, 4941492